CoinRX

CinRx Pharma is a Cincinnati-based biotech company that operates using a unique hub-and-spoke model to identify, fund, and accelerate the development of high-impact medicines. The company establishes individual subsidiaries, known as "CinCos," to house specific drug assets, sharing a central team of scientific and clinical experts to drive efficiency. Notable successes include CinCor Pharma, which was acquired by AstraZeneca for up to $1.8 billion, and a diverse pipeline spanning obesity, gastroparesis, and irritable bowel syndrome. CinRx is agnostic to therapeutic area and modality, focusing on assets with strong proof-of-concept potential.